HDAC2, a histone deacetylase, reportedly promoted cell cycle progression of breast cancer cell lines, since CRISPR/Cas9‐mediated knockout induced reduction of the cells in S and G2/M phases [17]. Here, HDAC2 is linked to breast cancer.